Related Experiment Videos
Human malignant astrocytes express macrophage phenotype
S Leenstra1, P K Das, D Troost
1Department of Neurosurgery, University of Amsterdam, Academic Medical Centre, Netherlands.
Abstract:
Six well-characterized specimens of cultured astrocytoma cells were investigated with a panel of macrophage markers. Our results show that the macrophage markers OKM-1(CD11b), OKM5(CD36), EBM11(CD68), HAM56, Factor 13, alpha-1-antichymotrypsin, alpha-1-antitrypsin, ferritin and lysozyme are clearly reactive to neoplastic astrocytes whereas astrocytes in normal brain specimens are not reactive. In order to obtain further confirmation concerning the reactivity of tumor cells in vivo, we simultaneously measured by flow cytometric analysis DNA content and HAM56 immunoreactivity in a freshly obtained tumor specimen. In this experiment we found a marked reactivity of aneuploid cells to HAM56. The macrophage phenotype of malignant astrocytes may reflect a similarity in functions of these cells and tumor-associated macrophages which promote tumor growth via the production of growth factors and angiogenic factors. Furthermore, our findings implicate that demonstration of macrophages within malignant astrocytomas by using macrophage-specific antibodies must be cautiously considered.
Insights
Neoplastic astrocytes in astrocytomas express macrophage markers, suggesting a shared functional role with tumor-associated macrophages. This finding necessitates caution when identifying macrophages in astrocytomas using specific antibodies.
Area of Science:
- Neuroscience
- Oncology
- Immunology
Background:
- Astrocytomas are primary brain tumors with significant heterogeneity.
- Tumor-associated macrophages (TAMs) are known to influence tumor progression.
- The cellular origin and phenotype of neoplastic astrocytes require further clarification.
Purpose of the Study:
- To investigate the expression of macrophage markers on cultured astrocytoma cells.
- To confirm the in vivo reactivity of tumor cells with macrophage markers.
- To explore the functional implications of macrophage markers on neoplastic astrocytes.
Main Methods:
- Immunohistochemical analysis of cultured astrocytoma cells using a panel of macrophage markers (e.g., CD11b, CD36, CD68, HAM56).
- Flow cytometric analysis of fresh astrocytoma specimens measuring DNA content and HAM56 immunoreactivity.
- Comparison of marker expression in neoplastic astrocytes versus normal brain astrocytes.
Main Results:
- Cultured neoplastic astrocytes exhibited reactivity to multiple macrophage markers, unlike normal astrocytes.
- In vivo analysis confirmed HAM56 reactivity in aneuploid tumor cells.
- The observed macrophage phenotype suggests functional similarities between neoplastic astrocytes and TAMs.
Conclusions:
- Neoplastic astrocytes share a macrophage-like phenotype, indicated by the expression of macrophage-specific markers.
- This phenotype may imply similar functions to TAMs, potentially promoting tumor growth.
- The presence of macrophage markers on neoplastic astrocytes warrants careful interpretation when diagnosing astrocytomas.